Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vanda Pharmaceuticals

4.24
-0.0800-1.85%
Pre-market: 4.20-0.0400-0.94%08:32 EDT
Volume:361.22K
Turnover:1.54M
Market Cap:249.88M
PE:-5.57
High:4.36
Open:4.30
Low:4.21
Close:4.32
Loading ...
May 26, 2020

Major Issues Report

8-K - Current report
May 13, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 13, 2020

Major Issues Report

Current report, item 8.01
Mar 03, 2020

Major Issues Report

Current report, item 5.02
Feb 26, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 26, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 20, 2020

Major Issues Report

Current report, item 5.02
Feb 19, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Jan 21, 2020

Major Issues Report

Current report, item 5.02